These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33484755)

  • 1. Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the "real-life".
    Monteleone P; Cascino G; Monteleone AM; Rocca P; Rossi A; Bertolino A; Aguglia E; Amore M; Collantoni E; Corrivetti G; Cuomo A; Bellomo A; D'Ambrosio E; Dell'Osso L; Frascarelli M; Giordano GM; Giuliani L; Marchesi C; Montemagni C; Oldani L; Pinna F; Pompili M; Roncone R; Rossi R; Siracusano A; Vita A; Zeppegno P; Galderisi S; Maj M;
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110250. PubMed ID: 33484755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study.
    Monteleone P; Cascino G; Rossi A; Rocca P; Bertolino A; Aguglia E; Amore M; Andriola I; Bellomo A; Biondi M; Brasso C; Carpiniello B; Collantoni E; Dell'Osso L; di Giannantonio M; Fabrazzo M; Fagiolini A; Giordano GM; Marcatili M; Marchesi C; Monteleone AM; Pompili M; Roncone R; Siracusano A; Vita A; Zeppegno P; Galderisi S; Maj M;
    Schizophr Res; 2022 Oct; 248():279-286. PubMed ID: 36116319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.
    Miller CH; Mohr F; Umbricht D; Woerner M; Fleischhacker WW; Lieberman JA
    J Clin Psychiatry; 1998 Feb; 59(2):69-75. PubMed ID: 9501888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?
    Weiser M; Shneider-Beeri M; Nakash N; Brill N; Bawnik O; Reiss S; Hocherman S; Davidson M
    Schizophr Res; 2000 Dec; 46(2-3):81-9. PubMed ID: 11120419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic treatment in older schizophrenia patients with extrapyramidal side effects in Asia (2001 - 2009).
    Xiang YT; Kreyenbuhl J; Dickerson FB; Ungvari GS; Wang CY; Si TM; Lee EH; Chiu HF; Lai KY; He YL; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Int J Clin Pharmacol Ther; 2012 Jul; 50(7):500-4. PubMed ID: 22541750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone.
    Kopala LC; Good KP; Honer WG
    J Clin Psychopharmacol; 1997 Aug; 17(4):308-13. PubMed ID: 9241011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral cortical gray expansion associated with two second-generation antipsychotics.
    Garver DL; Holcomb JA; Christensen JD
    Biol Psychiatry; 2005 Jul; 58(1):62-6. PubMed ID: 15992524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia.
    Fervaha G; Agid O; Takeuchi H; Lee J; Foussias G; Zakzanis KK; Graff-Guerrero A; Remington G
    Schizophr Res; 2015 Feb; 161(2-3):351-6. PubMed ID: 25471015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotics in the treatment of schizophrenia: an overview.
    Tandon R
    J Clin Psychiatry; 2011; 72 Suppl 1():4-8. PubMed ID: 22217436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.
    Veselinović T; Scharpenberg M; Heinze M; Cordes J; Mühlbauer B; Juckel G; Habel U; Rüther E; Timm J; Gründer G;
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):720-739. PubMed ID: 30981585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics.
    Zhand N; Labelle A; Ghanem D; Gujral P; Han T; Huneault G; Jain GK; Robertson C
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):475-479. PubMed ID: 35977035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone.
    Caligiuri MP; Teulings HL; Dean CE; Niculescu AB; Lohr J
    Hum Mov Sci; 2009 Oct; 28(5):633-42. PubMed ID: 19692133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons.
    Haddad PM; Das A; Keyhani S; Chaudhry IB
    J Psychopharmacol; 2012 May; 26(5 Suppl):15-26. PubMed ID: 22057019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic use in hospitalised schizophrenic patients in Belgium.
    De Hert M; Wampers M; van Winkel R; Peuskens J
    Psychiatry Res; 2007 Aug; 152(2-3):165-72. PubMed ID: 17445906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal Symptoms During Risperidone Maintenance Treatment in Schizophrenia: A Prospective, Multicenter Study.
    Bo QJ; Li XB; Wang ZM; Li AN; Ma X; Wang CY
    J Clin Psychopharmacol; 2016 Apr; 36(2):125-9. PubMed ID: 26848792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic use in children and adolescents after initiation of antipsychotic therapy.
    Hong IS; Bishop JR
    Ann Pharmacother; 2010; 44(7-8):1171-80. PubMed ID: 20587746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.